Patient characteristics
| . | Number of patients . |
|---|---|
| Sex | |
| Male | 5 (42%) |
| Female | 7 (58%) |
| Age, median (range), y | 66 (48-79) |
| Background bowel function | |
| Normal | 5 (42%) |
| Lifelong intermittent loose stool | 3 (25%) |
| Other GI history (not diarrhea) | 4 (33%) |
| Time to deterioration of bowel function following lenalidomide commencement, median (range), mo | 6 (1-15) |
| Dose of lenalidomide | |
| 25 mg | 5 (41%) |
| 10-15 mg | 7 (58%) |
| Symptoms | |
| Diarrhea* | 12 (100%) |
| Urgency | 11 (92%) |
| Fecal incontinence | 7 (58%) |
| Abdominal cramps | 5 (42%) |
| . | Number of patients . |
|---|---|
| Sex | |
| Male | 5 (42%) |
| Female | 7 (58%) |
| Age, median (range), y | 66 (48-79) |
| Background bowel function | |
| Normal | 5 (42%) |
| Lifelong intermittent loose stool | 3 (25%) |
| Other GI history (not diarrhea) | 4 (33%) |
| Time to deterioration of bowel function following lenalidomide commencement, median (range), mo | 6 (1-15) |
| Dose of lenalidomide | |
| 25 mg | 5 (41%) |
| 10-15 mg | 7 (58%) |
| Symptoms | |
| Diarrhea* | 12 (100%) |
| Urgency | 11 (92%) |
| Fecal incontinence | 7 (58%) |
| Abdominal cramps | 5 (42%) |
Data are presented as n (%) of patients unless indicated otherwise.
Defined by Bristol Stool Chart (BSC) score 6 or 7. Median stool frequency: 6 episodes per day (range, 1-10).